Quarterly Statement Of Cash Flows

Modalis Therapeutics Corporation - Filing #7571290

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,888,492,000 JPY
-1,232,400,000 JPY
Interest and dividends received
57,000 JPY
57,000 JPY
Interest paid
-6,128,000 JPY
JPY
Income taxes paid
-1,210,000 JPY
-1,210,000 JPY
Net cash provided by (used in) operating activities
-1,895,773,000 JPY
-747,466,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-197,287,000 JPY
-107,111,000 JPY
Other, net
JPY
332,000 JPY
Net cash provided by (used in) investing activities
-185,719,000 JPY
171,563,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-97,000 JPY
Other, net
-910,000 JPY
JPY
Net cash provided by (used in) financing activities
63,683,000 JPY
72,633,000 JPY
Effect of exchange rate change on cash and cash equivalents
14,778,000 JPY
17,987,000 JPY
Net increase (decrease) in cash and cash equivalents
-2,003,031,000 JPY
-485,282,000 JPY
Cash and cash equivalents
2,933,162,000 JPY
4,936,193,000 JPY
5,421,476,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.